- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
5.—(1) Schedule 17 (exemption for sale, supply or administration by certain persons) is amended as follows—
(2) In Part 2 (exemption from the restriction on supply of prescription only medicines)(1), in paragraph 1, after item 12 insert—
“13. Registered dental therapists or registered dental hygienists who are qualified to use the medicines specified in column 2. | 13. The following prescription only medicines— (a) Lidocaine 2% with 1:80,000 adrenaline, (b) Articaine hydrochloride 4% with 1:100,000 adrenaline, (c) Articaine hydrochloride 4% with 1:200,000 adrenaline, (d) 3% Mepivacaine hydrochloride, (e) 3% Prilocaine with 0.54 microgram/ml felypressin, (f) 2.5%/2.5% Lidocaine and prilocaine peridontal gel, (g) Sodium fluoride varnish, 50mg/ml (2.26%) dental suspension (containing 22600ppm fluoride), (h) Minocyline 2% periodontal gel, (i) Sodium fluoride 0.619% (2800ppm fluoride) dental paste, (j) Sodium fluoride 1.1% (5000ppm fluoride) dental paste, (k) 15% Lidocaine, 0.15% cetrimide oromucosal spray, (l) Nystatin oral suspension. | 13. The supply shall be only in the course of their professional practice.”. |
(3) In Part 3 (exemptions from the restriction on administration of prescription only medicine)(2), in paragraph 1, after item 11 insert—
“12. Registered dental therapists or registered dental hygienists who are qualified to use the medicines specified in column 2. | 12. The following prescription only medicines for parenteral administration— (a) 2% Lidocaine with 1:80,000 adrenaline, (b) Articaine hydrochloride 4% with 1:100,000 adrenaline, (c) Articaine hydrochloride 4% with 1:200,000 adrenaline, (d) 3% Mepivacaine hydrochloride, (e) 3% Prilocaine with 0.54 microgram/ml felypressin. | 12. The administration shall be only in the course of their professional practice.”. |
(4) In Part 4 (exemption from the restriction in regulations 220 and 221 for certain persons who sell, supply, or offer for sale or supply certain medicinal products)(3), in paragraph 1, after item 13 insert—
“14. Registered dental therapists or registered dental hygienists who are qualified to use the medicines specified in column 2. | 14. All medicinal products on a general sale list, all pharmacy medicines and the following prescription only medicines which are not for parenteral administration— (a) 2.5%/2.5% Lidocaine and prilocaine periodontal gel, (b) Sodium fluoride varnish, 50mg/ml (2.26%) dental suspension (containing 22600ppm fluoride), (c) Minocycline 2% periodontal gel, (d) Sodium fluoride 0.619% (2800ppm fluoride) dental paste, (e) Sodium fluoride 1.1% (5000ppm) dental paste, (f) 15% Lidocaine, 0.15% cetrimide oromucosal spray, (g) Nystatin oral suspension. | 14. The sale, supply or offer for sale or supply shall be only in the course of their professional practice.”. |
Item 12 was added to the table in paragraph 1 by S.I. 2016/186. There are other amending instruments but none is relevant.
Item 11 was added to the table in paragraph 1 by S.I. 2017/715. There are other amending instruments but none is relevant.
Item 13 was added to the table in paragraph 1 by S.I. 2016/186 and amended by 2017/715. There are other amendments not relevant to these Regulations.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: